Regulatory Considerations for Developing Orphan Drugs
Developing orphan drugs involves navigating a complex regulatory landscape. Agencies like the FDA and EMA provide incentives such as expedited review processes, grants, and market exclusivity to stimulate orphan drug development. However, the limited size of clinical trial populations presents challenges for meeting rigorous safety and efficacy standards. Real-world evidence and adaptive clinical trial designs are increasingly important for supporting regulatory approval. Clear communication between stakeholders ensures patient safety while facilitating timely access to new therapies.
Related Conference of Regulatory Considerations for Developing Orphan Drugs
December 10-11, 2024
19th World Conference on Infectious Diseases, Prevention and Control
Dubai, UAE
January 30-31, 2025
9th International Conference on Infectious Diseases: Control and Prevention
London, UK
May 21-22, 2025
12th International Conference on Infectious Diseases, Bacteriology and Antibiotics
Paris, France
June 16-17, 2025
5th International Conference on Microbiology and Infectious Diseases
Amsterdam, Netherlands
June 24-25, 2025
6th Annual Meeting on Infectious Diseases, Microbiology & Beneficial Microbes
Paris, France
Regulatory Considerations for Developing Orphan Drugs Conference Speakers
Recommended Sessions
- Advancement in the Diagnosis of Rare Diseases
- Biomarkers for Rare Disease Diagnosis and Treatment
- Biomedical Research
- Challenges of Living with a Rare Disease
- Clinical Case Reports and Case Studies
- Clinical Research on Orphan Drugs
- Different Types of Rare Diseases
- Drug Discovery for Rare Diseases
- Emerging Technologies in Rare Disease Research
- Functional Genomics and Gene Therapy for Rare Diseases
- Genetic Testing and Counselling of Rare Diseases
- Health Economics and Market Access for Orphan Drugs
- Infectious Diseases and Immune Deficiencies
- Introduction and Causes of New Rare Diseases
- Orphan Drugs Potentiality
- Rare Autoimmune Disorders
- Rare Bone Diseases
- Rare Cancer
- Rare Diseases and Orphan Drugs
- Rare Diseases of the Heart and Vessels
- Rare Neurological Disorders
- Rare Nutritional and Metabolic Diseases
- Rare Paediatric Diseases
- Rare Skin Diseases
- Regulatory Considerations for Developing Orphan Drugs
- Treatment and Advanced Therapies for Rare Diseases
- Vaccines and Vaccination for Rare Diseases
Related Journals
Are you interested in
- 1.Infectious Diseases and Neuro Infectious Diseases - Infectious Diseases_2025 (Canada)
- 10. HIV/AIDS - Infectious Diseases_2025 (Canada)
- 11. Pediatric Infectious Diseases/ Childhood Infectious Diseases - Infectious Diseases_2025 (Canada)
- 12. Respiratory Diseases - Infectious Diseases_2025 (Canada)
- 13. Sexually Transmitted Diseases/ Sexually Transmitted Infections - Infectious Diseases_2025 (Canada)
- 14. Viral Infectious Diseases - Infectious Diseases_2025 (Canada)
- 15. Malaria and Hepatitis - Infectious Diseases_2025 (Canada)
- 16. Immunology of Infections - Infectious Diseases_2025 (Canada)
- 17. Vaccines and Vaccination - Infectious Diseases_2025 (Canada)
- 18. Tuberculosis - Infectious Diseases_2025 (Canada)
- 19. New Antiviral, Antibacterial and Antifungal Agents - Infectious Diseases_2025 (Canada)
- 2. Coronavirus(nCOV) - Infectious Diseases_2025 (Canada)
- 20. Nosocomial Infections - Infectious Diseases_2025 (Canada)
- 21. Parasitic Diseases - Infectious Diseases_2025 (Canada)
- 22. Surgical Site Infections - Infectious Diseases_2025 (Canada)
- 3. Infectious Diseases Prevention, Control and Cure - Infectious Diseases_2025 (Canada)
- 4. Bacterial & Fungal Infectious Diseases - Infectious Diseases_2025 (Canada)
- 5. Rare Infectious Diseases and Immune Deficiencies - Infectious Diseases_2025 (Canada)
- 6. Rare Diseases in Cancer and Aging - Infectious Diseases_2025 (Canada)
- 7. Global Trends in Emerging Infectious Diseases - Infectious Diseases_2025 (Canada)
- 8. Ebola and Zika Viral Infections - Infectious Diseases_2025 (Canada)
- 9. Clinical Research and Public Awareness - Infectious Diseases_2025 (Canada)
- Advancement in the Diagnosis of Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Advancements in Vaccines and Therapeutics - Infectious Diseases 2025 (France)
- Antigen-Antibody Reactions - Infectious Diseases 2025 (France)
- Antimicrobial Stewardship/Antimicrobial Resistance - Infection Prevention 2024 (France)
- Bacterial Infections and Diseases - Infectious Diseases 2025 (France)
- Bacterial Infectious Diseases - BACTERIAL DISEASES 2024 (UAE)
- Bacterial Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Bacterial Infectious Diseases - Infection Congress 2025 (Germany)
- Bacterial, Parasitic and Fungal Infections - Infection Prevention 2024 (France)
- Bacterial, Viral, Fungal Infections - INFECTIOUS DISEASES CONF 2024 (UAE)
- Basic Virology - Virology 2024 (Italy)
- Biofertilizers - Infectious Diseases 2025 (France)
- Biomarkers for Rare Disease Diagnosis and Treatment - Rare Diseases Congress 2025 (Netherlands)
- Biomedical Research - Rare Diseases Congress 2025 (Netherlands)
- Blood Borne Infections/Sepsis/Septicaemia - Infection Prevention 2024 (France)
- Bloodborne infectious diseases, - Infection Congress 2025 (Germany)
- Causes and Symptoms of Infections - Infection Prevention 2024 (France)
- Causes and Symptoms of Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Challenges of Living with a Rare Disease - Rare Diseases Congress 2025 (Netherlands)
- Clinical analysis and Treatment - WORLD RARE DISEASES 2025 (Czech Republic)
- Clinical and Case Reports - INFECTIOUS DISEASES CONF 2024 (UAE)
- Clinical and Case Reports - INFECTIOUS DISEASES-2025 (France)
- Clinical Case Reports and Case Studies - Rare Diseases Congress 2025 (Netherlands)
- Clinical Management of Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Clinical Research on Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Clinical Virology - Virology 2024 (Italy)
- Coronavirus Disease (COVID-19) - BACTERIAL DISEASES 2024 (UAE)
- Coronavirus Disease (COVID-19) - INFECTIOUS DISEASES-2025 (France)
- COVID-19 - Infectious Diseases 2025 (France)
- COVID-19 Infection - Infection Congress 2025 (Germany)
- COVID-19, SARS & MERS - INFECTIOUS DISEASES CONF 2024 (UAE)
- Covid_19 Infections - Infection Prevention 2024 (France)
- Diagnosing infectious diseases - Infection Congress 2025 (Germany)
- Diagnosis Of infectious Diseases - Infection Prevention 2024 (France)
- Different Types of Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Disinfection and Sterilization - Infection Control 2025 (UK)
- Drug Discovery for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Drug Interaction in Infectious Diseases - INFECTIOUS DISEASES CONF 2024 (UAE)
- Ebola virus disease (EVD) & Zika virus - Infection Congress 2025 (Germany)
- Emerging and Re-Emerging Infections - Infection Prevention 2024 (France)
- Emerging and Re-Emerging Infections - Infection Congress 2025 (Germany)
- Emerging Infectious Diseases - Infection Control 2025 (UK)
- Emerging Infectious Diseases & Recent Outbreaks - INFECTIOUS DISEASES CONF 2024 (UAE)
- Emerging Technologies in Rare Disease Research - Rare Diseases Congress 2025 (Netherlands)
- Epidemiology - Infection Prevention 2024 (France)
- Epidemiology - INFECTIOUS DISEASES-2025 (France)
- Epidemiology and Public Health - INFECTIOUS DISEASES CONF 2024 (UAE)
- Epidemiology of Infectious Diseases - Infection Congress 2025 (Germany)
- Food and waterborne Infections - Infection Congress 2025 (Germany)
- Food Borne & Water Borne Infections - INFECTIOUS DISEASES CONF 2024 (UAE)
- Functional Genomics and Gene Therapy for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Fungal Infections - Infectious Diseases 2025 (France)
- Fungal Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Fungal Infectious Diseases - Infection Congress 2025 (Germany)
- Gastrointestinal and Urinary tract Infections - Infection Prevention 2024 (France)
- Gastrointestinal and urinary tract infections - Infection Congress 2025 (Germany)
- Gene Expression - Infectious Diseases 2025 (France)
- Genetic Testing and Counselling of Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Global Trends in Emerging Infections - Infection Prevention 2024 (France)
- Health Economics and Market Access for Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Hepatitis Prevention - Infection Prevention 2024 (France)
- Hepatitis Prevention - Infection Control 2025 (UK)
- HIV Prevention, Treatment and Cure - Infection Control 2025 (UK)
- Immunizations and Vaccination - Infection Prevention 2024 (France)
- Infection Control & Public Awareness - INFECTIOUS DISEASES CONF 2024 (UAE)
- Infection Control Bacteriology - Infection Control 2025 (UK)
- Infection Control Business - Infection Control 2025 (UK)
- Infection Control in Critical Care - Infection Prevention 2024 (France)
- Infection Control in Dental - Infection Control 2025 (UK)
- Infection Control Precautions - Infection Control 2025 (UK)
- Infection Control Procedures - Infection Prevention 2024 (France)
- Infection Control Treatment & Diagnosis - Infection Control 2025 (UK)
- Infection Prevention and Control - Infection Prevention 2024 (France)
- Infection Treatment and Control - Infection Control 2025 (UK)
- Infection, Immunity and Inflammation - INFECTIOUS DISEASES-2025 (France)
- Infection, Immunity and Inflammation - INFECTIOUS DISEASES-2025 (France)
- Infectious Disease Pathology - Infection Control 2025 (UK)
- Infectious Diseases - BACTERIAL DISEASES 2024 (UAE)
- Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Infectious Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Infectious Diseases - Infection Congress 2025 (Germany)
- Infectious Diseases and Cancer - Infectious Diseases 2025 (France)
- Infectious Diseases and Immune Deficiencies - Rare Diseases Congress 2025 (Netherlands)
- Infectious Diseases and Vaccines - INFECTIOUS DISEASES CONF 2024 (UAE)
- Infectious Diseases caused by Influenza virus - INFECTIOUS DISEASES CONF 2024 (UAE)
- Infectious Diseases Epidemiology - INFECTIOUS DISEASES-2025 (France)
- Infectious Diseases Prevention, Control and Cure - INFECTIOUS DISEASES-2025 (France)
- Infectious Diseases, Prevention & Control - INFECTIOUS DISEASES CONF 2024 (UAE)
- Influenza and Diagnostic Approaches - Infection Control 2025 (UK)
- Internal Medicine for Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Introduction and Causes of New Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Mutations - Infectious Diseases 2025 (France)
- Mystery designation of Rare Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Neglected Tropical Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Neuro Infections - Infection Prevention 2024 (France)
- Neuro infections - Infection Congress 2025 (Germany)
- Neuro Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Nosocomial Infections & Control - Infection Control 2025 (UK)
- Nosocomial Infections & Control - INFECTIOUS DISEASES-2025 (France)
- Nosocomial Infections and Control - Infection Prevention 2024 (France)
- Nursing Infection Control - Infection Control 2025 (UK)
- One Health Approaches to Virology - Virology 2024 (Italy)
- Ophthalmological Infections - Infection Prevention 2024 (France)
- Orphan Drugs Potentiality - Rare Diseases Congress 2025 (Netherlands)
- Orphan medicine - WORLD RARE DISEASES 2025 (Czech Republic)
- Paediatric Infectious Diseases - Infection Prevention 2024 (France)
- Parasitic Infections - Infectious Diseases 2025 (France)
- Parasitic Infectious Diseases - Infection Congress 2025 (Germany)
- Parasitology & Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Pathology and Microbiology - INFECTIOUS DISEASES CONF 2024 (UAE)
- Pediatric Infectious Diseases - INFECTIOUS DISEASES CONF 2024 (UAE)
- Pediatric Infectious Diseases - Infection Control 2025 (UK)
- Pediatric Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Pharmacology of Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Plants Diseases and Infection Control - Infection Prevention 2024 (France)
- Practical Guidelines - Infection Control 2025 (UK)
- Practices & Awareness - Infection Control 2025 (UK)
- Prion Diseases - Infectious Diseases 2025 (France)
- Probiotics and Prebiotics - Infectious Diseases 2025 (France)
- Public Health and Epidemiology - Virology 2024 (Italy)
- Pulmonary and Chest Infections - Infection Congress 2025 (Germany)
- Pulmonary Infection Therapy - Infection Congress 2025 (Germany)
- Rare Autoimmune Disorders - Rare Diseases Congress 2025 (Netherlands)
- Rare Bone Diseases - Rare Diseases Congress 2025 (Netherlands)
- Rare Cancer - Rare Diseases Congress 2025 (Netherlands)
- Rare Cancer Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Diseases analysis - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Diseases and Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Rare Diseases in Brain - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Diseases of the Heart and Vessels - Rare Diseases Congress 2025 (Netherlands)
- Rare Endocrine Genetic Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Genetic Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare hematology Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Infectious Diseases - Infection Prevention 2024 (France)
- Rare Neurological Disorders - Rare Diseases Congress 2025 (Netherlands)
- Rare Nutritional and Metabolic Diseases - Rare Diseases Congress 2025 (Netherlands)
- Rare Paediatric Diseases - Rare Diseases Congress 2025 (Netherlands)
- Rare paediatrics Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare response Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Skin Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Skin Diseases - Rare Diseases Congress 2025 (Netherlands)
- Regulatory Considerations for Developing Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Research on Medicine and Vaccine for Covid-19 - INFECTIOUS DISEASES-2025 (France)
- Respiratory and Blood Infections - INFECTIOUS DISEASES CONF 2024 (UAE)
- Respiratory Infectious Diseases and Therapy - Infection Prevention 2024 (France)
- Risk Factors & Prevention - Infection Control 2025 (UK)
- Sexually Transmitted Diseases - Infection Prevention 2024 (France)
- Sexually Transmitted Diseases (STDs) and Infections (STIs) - Infectious Diseases 2025 (France)
- Sexually transmitted diseases STDs - Infection Congress 2025 (Germany)
- STD (Sexually Transmitted Diseases) and Control - INFECTIOUS DISEASES CONF 2024 (UAE)
- Surgical Site Infections - Infection Prevention 2024 (France)
- Therapeutics and Antiviral Agents - Virology 2024 (Italy)
- Treatment and Advanced Therapies for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Treatment for Rare Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Treatment for Tuberculosis - Infection Control 2025 (UK)
- Tropical diseases - Infection Prevention 2024 (France)
- Tropical Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Vaccine Research & Development - Infection Control 2025 (UK)
- Vaccines and Vaccination - INFECTIOUS DISEASES-2025 (France)
- Vaccines and Vaccination for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Veterinary Diseases - Infection Prevention 2024 (France)
- Veterinary Diseases - INFECTIOUS DISEASES-2025 (France)
- Veterinary Infection Control - Infection Control 2025 (UK)
- Veterinary Infectious Diseases - Infectious Diseases 2025 (France)
- Viral Diagnostics and Laboratory Techniques - Virology 2024 (Italy)
- Viral Ecology and Evolution - Virology 2024 (Italy)
- Viral Genomics and Bioinformatics - Virology 2024 (Italy)
- Viral Infections and Diseases - Infectious Diseases 2025 (France)
- Viral Infections and Recent Advancements - Infection Prevention 2024 (France)
- Viral Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Viral Pathogenesis - Virology 2024 (Italy)
- Viral Vaccines and Immunology - Virology 2024 (Italy)